Loss of Nicotine-Induced Behavioral Sensitization in μ-Opioid Receptor Knockout Mice

Synapse

Volumn 51, Issue 4, 2004, Pages 219-223

  Yoo, Ji Hoon ^a   Lee, Seok Yong ^a   Loh, Horace H ^b   Ho, Ing K ^c   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

opioid receptor knockout mice; Locomotor activity; Nicotine; Sensitization

Indexed keywords

MU OPIATE RECEPTOR; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; WILD TYPE;

ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; RECEPTORS, OPIOID, MU;

EID: 0942276231     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10303     Document Type: Article

References (27)

1. Antelman SM, Soares JC, Gershon S. 1997. Time-dependent sensitization-possible implications for clinical psychopharmacology. Behav Pharmacol 8:505-514.
2. Berrendero F, Kieffer BL, Maldonado R. 2002. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci 22:10935-10940.
3. Brauer LH, Behm FM, Westman EC, Patel P, Rose JE. 1999. Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology (Berl) 143:339-346.
4. Collins AC, Miner LL, Marks MJ. 1988. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav 30:269-278.
5. Conte-Devolx B, Oliver C, Giraud P, Gillioz P, Castanas E, Lissitzky JC, Boudouresque F, Millet Y. 1981. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sci 28:1067-1073.
6. Corrigall WA, Herling S, Coen KM. 1988. Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology (Berl) 96:29-35.
7. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. 1997. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132:107-124.
8. Domino EF. 2001. Nicotine induced behavioral locomotor sensitization. Prog Neuropsychopharmacol Biol Psychiatry 25:59-71.
9. Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, Niaura RS, Sirota AD. 1999. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacology (Berl) 142:139-143.
10. Karras A, Kane JM. 1980. Naloxone reduces cigarette smoking. Life Sci 27:1541-1545.
11. Kim HS, Kim KS. 1999. Inhibitory effects of ginseng total saponin on nicotine-induced hyperactivity, reverse tolerance and dopamine receptor supersensitivity. Behav Brain Res 103:55-61.
12. Ksir C, Hakan RL, Kellar KJ. 1987. Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl) 92:25-29.
13. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. 1998. μ-Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Mol Brain Res 54:321-326.
14. Louis M, Clarke PB. 1998. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology 37:1503-1513.
15. Maisonneuve IM, Glick SD. 1999. (+/-)Cyclazocine blocks the dopamine response to nicotine. Neuroreport 10:693-696.
16. Malin DH, Lake JR, Carter VA, Cunningham JS, Hebert KM, Conrad DL, Wilson OB. 1994. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl) 115:180-184.
17. Malin DH, Lake JR, Payne MC, Short PE, Carter VA, Cunningham JS, Wilson OB. 1996. Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacol Biochem Behav 53:81-85.
18. Pierzchala K, Houdi AA, Van Loon GR. 1987. Nicotine-induced alterations in brain regional concentrations of native and cryptic Met-and Leu-enkephalin. Peptides 8:1035-1043.
19. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
20. Rose JE, Corrigall WA. 1997. Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl) 130:28-40.
21. Shim I, Javaid JI, Wirtshafter D, Jang SY, Shin KH, Lee HJ, Chung YC, Chun BG. 2001. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav Brain Res 121:137-147.
22. Tanda G, Di Chiara G. 1998. A dopamine-μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and nonpsychostimulant drugs of abuse. Eur J Neurosci 10:1179-1187.
23. Tzschentke TM. 1998. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
24. Watkins SS, Koob GF, Markou A. 2000. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19-37.
25. Wewers ME, Dhatt R, Tejwani GA. 1998. Naltrexone administration affects ad libitum smoking behavior. Psychopharmacology (Berl) 140:185-190.
26. Yoo JH, Yang EM, Lee SY, Loh HH, Ho IK, Jang CG. 2003. Differential effects of morphine and cocaine on locomotor activity and sensitization in μ-opioid receptor knockout mice. Neurosci Lett 344:37-40.
27. Zarrindast MR, Faraji N, Rostami P, Sahraei H, Ghoshouni H. 2003. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol Biochem Behav 74:363-369.